These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 33117161)
1. Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs. Wong HN; Lewies A; Haigh M; Viljoen JM; Wentzel JF; Haynes RK; du Plessis LH Front Pharmacol; 2020; 11():558894. PubMed ID: 33117161 [TBL] [Abstract][Full Text] [Related]
2. Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage Wong HN; Padín-Irizarry V; van der Watt ME; Reader J; Liebenberg W; Wiesner L; Smith P; Eribez K; Winzeler EA; Kyle DE; Birkholtz LM; Coertzen D; Haynes RK Front Chem; 2019; 7():901. PubMed ID: 31998692 [TBL] [Abstract][Full Text] [Related]
3. Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue. Ng JPL; Han Y; Yang LJ; Birkholtz LM; Coertzen D; Wong HN; Haynes RK; Coghi P; Wong VKW Front Pharmacol; 2022; 13():988748. PubMed ID: 36120293 [TBL] [Abstract][Full Text] [Related]
4. Facile Preparation of Wu Y; Parapini S; Williams ID; Misiano P; Wong HN; Taramelli D; Basilico N; Haynes RK Molecules; 2018 Jul; 23(7):. PubMed ID: 30011856 [TBL] [Abstract][Full Text] [Related]
5. In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells. Dwivedi A; Mazumder A; du Plessis L; du Preez JL; Haynes RK; du Plessis J Nanomedicine; 2015 Nov; 11(8):2041-50. PubMed ID: 26282380 [TBL] [Abstract][Full Text] [Related]
6. The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage Gibhard L; Coertzen D; Reader J; van der Watt ME; Birkholtz LM; Wong HN; Batty KT; Haynes RK; Wiesner L Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959347 [TBL] [Abstract][Full Text] [Related]
7. Elimination of Schistosoma mansoni in infected mice by slow release of artemisone. Gold D; Alian M; Domb A; Karawani Y; Jbarien M; Chollet J; Haynes RK; Wong HN; Buchholz V; Greiner A; Golenser J Int J Parasitol Drugs Drug Resist; 2017 Aug; 7(2):241-247. PubMed ID: 28511056 [TBL] [Abstract][Full Text] [Related]
8. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication. Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656 [TBL] [Abstract][Full Text] [Related]
9. Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins. Watson DJ; Laing L; Petzer JP; Wong HN; Parkinson CJ; Wiesner L; Haynes RK Front Pharmacol; 2023; 14():1308400. PubMed ID: 38259296 [TBL] [Abstract][Full Text] [Related]
10. Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus. Oiknine-Djian E; Bar-On S; Laskov I; Lantsberg D; Haynes RK; Panet A; Wolf DG Antiviral Res; 2019 Dec; 172():104639. PubMed ID: 31654672 [TBL] [Abstract][Full Text] [Related]
11. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo. Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512 [TBL] [Abstract][Full Text] [Related]
12. Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment. Kumar MS; Yadav TT; Khair RR; Peters GJ; Yergeri MC Curr Pharm Des; 2019; 25(31):3323-3338. PubMed ID: 31475891 [TBL] [Abstract][Full Text] [Related]
13. Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells. Raineri A; Prodomini S; Fasoli S; Gotte G; Menegazzi M Biochem Pharmacol; 2019 Sep; 167():173-181. PubMed ID: 31185226 [TBL] [Abstract][Full Text] [Related]
14. Methylene Homologues of Artemisone: An Unexpected Structure-Activity Relationship and a Possible Implication for the Design of C10-Substituted Artemisinins. Wu Y; Wu RW; Cheu KW; Williams ID; Krishna S; Slavic K; Gravett AM; Liu WM; Wong HN; Haynes RK ChemMedChem; 2016 Jul; 11(13):1469-79. PubMed ID: 27273875 [TBL] [Abstract][Full Text] [Related]
15. Controlled release of artemisone for the treatment of experimental cerebral malaria. Golenser J; Buchholz V; Bagheri A; Nasereddin A; Dzikowski R; Guo J; Hunt NH; Eyal S; Vakruk N; Greiner A Parasit Vectors; 2017 Mar; 10(1):117. PubMed ID: 28249591 [TBL] [Abstract][Full Text] [Related]
16. Phenethyl isothiocyanate triggers apoptosis in human malignant melanoma A375.S2 cells through reactive oxygen species and the mitochondria-dependent pathways. Huang SH; Hsu MH; Hsu SC; Yang JS; Huang WW; Huang AC; Hsiao YP; Yu CC; Chung JG Hum Exp Toxicol; 2014 Mar; 33(3):270-83. PubMed ID: 23760257 [TBL] [Abstract][Full Text] [Related]
17. Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives. Wu L; Pang Y; Qin G; Xi G; Wu S; Wang X; Chen T PLoS One; 2017; 12(2):e0171840. PubMed ID: 28182780 [TBL] [Abstract][Full Text] [Related]
18. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo. Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154 [TBL] [Abstract][Full Text] [Related]
19. Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy. Chatterjee SJ; Pandey S Cancer Biol Ther; 2011 Jan; 11(2):216-28. PubMed ID: 21088500 [TBL] [Abstract][Full Text] [Related]
20. Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines. Scott J; Dorr RT; Samulitis B; Landowski TH Cancer Chemother Pharmacol; 2007 May; 59(6):749-57. PubMed ID: 17333195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]